Eli Lilly and Company
Sidney Taurel to Retire as Lilly CEO; John Lechleiter Named as Successor
Published in Bioterrorism Week, December 31st, 2007
Eli Lilly and Company (NYSE:LLY) announced that Sidney Taurel, chief executive officer and chairman of the board, will retire as CEO effective March 31, 2008. Taurel will remain chairman of the company's board of directors until December 31, 2008, at which time he will retire from the board and from the company. John C. Lechleiter, Ph.D., currently president and chief operating officer, will assume the role of president and chief executive officer as of April 1, 2008.
Taurel has been the company's chief executive officer since July, 1998, and the chairman of its board of directors since January 1, 1999. He joined Lilly in 1971 as a marketing associate in Eli Lilly...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Bioterrorism Week
Source: Bioterrorism Week (2007-12-31)
More Articles from Bioterrorism Week
- Vaccines
Research on vaccines detailed by scientists at University of Texas - Anthrax Cell Biology
Researchers from University of Sussex report recent findings in anthrax cell biology - Anthrax Cell Biology
Studies from College of Medicine provide new data on anthrax cell biology - Chemical Warfare
Research from University of Helsinki yields new findings on chemical warfare - Bioterrorism
New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies - Public Health
UPDATE: Significant Progress Made in Nation's Preparedness to Respond to Public Health Emergencies; but Gaps in Critical Areas Threaten Overall Readiness - More from this issue of Bioterrorism Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
